Results of treatment with Heberprot -P patients with a diagnosis of diabetic foot in the Municipality of Ranchuelo

Authors

  • María de Jesús Bustillo Santandreu Hospital Provincial Universitario “Arnaldo Milián Castro”, Santa Clara, Villa Clara
  • Teresita Regina Feito Castex Hospital Provincial Universitario “Arnaldo Milián Castro”, Santa Clara, Villa Clara
  • Felicia Vegoña García Seco Hospital Provincial Universitario “Arnaldo Milián Castro”, Santa Clara, Villa Clara
  • Yuslizan Álvarez López Hospital Provincial Universitario “Arnaldo Milián Castro”, Santa Clara, Villa Clara
  • Belkis María Guerra Durán Hospital Provincial Universitario “Arnaldo Milián Castro”, Santa Clara, Villa Clara

Keywords:

diabetic foot, treatment outcome

Abstract

Introduction: the diabetic foot syndrome is one of the chronic complications of increased morbidity and disability in diabetic patients today. High rates of amputations cause a significant degree of disability with high economic and social cost. It has been shown that administration of Heberprot- P stimulates the formation of granulation tissue in the ulcer bed and closed by second intention .
Objective: to describe the results of treatment with Heberprot -P in patients with a diagnosis of diabetic foot.
Material and methods: a prospective study of 86 patients with diagnosis of diabetic foot in the period January 2010 to December 2013 at the Policlinic "Juan Contreras B. Fowler" in Ranchuelo Municipality, in the Province of Villa Clara, which were applied to the epidermal growth factor intralesionally . Patients taking into account age, sex, personal medical history, the severity depending on the classification of Wagner , the dose and the number of applications, the assessment of response and adverse effects were studied.
Results: in the studied series predominated patients aged between 50 and 59 years old ( 26.74 %), females ( 52.33 %) and diabetes type 2; the number of applications was increased in the plantar ulcer grade III ; full granulation was achieved in 70 % of cases and partial in 24.4%; there was major amputation in two patients with adverse effects and they presented pain and burning.
Conclusions: with the implementation of Heberprot -P has been achieved a favorable outcome in most cases and iit s able to maintain the integrity of the member and its functionality in most patients.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Bustillo Santandreu M de J, Feito Castex TR, García Seco FV, Álvarez López Y, Guerra Durán BM. Results of treatment with Heberprot -P patients with a diagnosis of diabetic foot in the Municipality of Ranchuelo. Acta Méd Centro [Internet]. 2014 Jun. 28 [cited 2025 Jul. 1];8(2):16-22. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/115

Issue

Vol. 8 No. 2 (2014): April-June

Section

Original Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).